Filter

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Database licenses

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 6 result(s)

National Health and Disease Human Brain Tissue Resource Center

国家健康和疾病人脑组织资源库

Subject(s)
Content type(s)
Country
The National Human Brain Tissue Bank for Health and Disease (the Brain Bank) was built to meet the needs of scientific research by integrating experts and forces from neuroscience, human anatomy, pathology and other related disciplines. The Brain Bank collects and stores post-mortem brain tissue donated by patients with various neuropsychiatric disorders and normal controls, as well as their life histories, in accordance with international standards, and provides a detailed and accurate neuropathological diagnosis of these brain tissue samples (also known as the "final diagnosis"). The aim is to discover and elucidate the causes of human neuropsychiatric diseases such as Alzheimer's disease, Parkinson's disease, depression, schizophrenia and other human diseases, and to provide scientists with the most direct and effective means of finding the relevant pathogenesis and establishing effective treatments. The National Brain Tissue Resource for Health and Disease The goal of the National Human Brain Tissue Repository for Health and Disease is to integrate collection, diagnosis, storage and utilisation, and to build a first-class human resource preservation infrastructure in China that is in line with international standards and provides support for neuroscience research. In 2020, the National Brain Bank has established three branches of the National Brain Bank in Hefei, Anhui, Nanjing, Jiangsu, and Shanghai. major cities.

Cystic Fibrosis Mutation Database

CFTR1

Subject(s)
Content type(s)
Country
The Cystic Fibrosis Mutation Database (CFTR1) was initiated by the Cystic Fibrosis Genetic Analysis Consortium in 1989 to increase and facilitate communications among CF researchers, and is maintained by the Cystic Fibrosis Centre at the Hospital for Sick Children in Toronto. The specific aim of the database is to provide up to date information about individual mutations in the CFTR gene. In a major upgrade in 2010, all known CFTR mutations and sequence variants have been converted to the standard nomenclature recommended by the Human Genome Variation Society.

Immune Epitope Database

IEDB

Subject(s)
Content type(s)
Country
IEDB offers easy searching of experimental data characterizing antibody and T cell epitopes studied in humans, non-human primates, and other animal species. Epitopes involved in infectious disease, allergy, autoimmunity, and transplant are included. The IEDB also hosts tools to assist in the prediction and analysis of B cell and T cell epitopes.

Virtual Liver Network

VLN

Subject(s)
Content type(s)
Country
<<<!!!<<<no longer avialable>>>!!!>>>

International Mouse Phenotyping Consortium

IMPC

Subject(s)
Content type(s)
Country
The IMPC is a confederation of international mouse phenotyping projects working towards the agreed goals of the consortium: To undertake the phenotyping of 20,000 mouse mutants over a ten year period, providing the first functional annotation of a mammalian genome. Maintain and expand a world-wide consortium of institutions with capacity and expertise to produce germ line transmission of targeted knockout mutations in embryonic stem cells for 20,000 known and predicted mouse genes. Test each mutant mouse line through a broad based primary phenotyping pipeline in all the major adult organ systems and most areas of major human disease. Through this activity and employing data annotation tools, systematically aim to discover and ascribe biological function to each gene, driving new ideas and underpinning future research into biological systems; Maintain and expand collaborative “networks” with specialist phenotyping consortia or laboratories, providing standardized secondary level phenotyping that enriches the primary dataset, and end-user, project specific tertiary level phenotyping that adds value to the mammalian gene functional annotation and fosters hypothesis driven research; and Provide a centralized data centre and portal for free, unrestricted access to primary and secondary data by the scientific community, promoting sharing of data, genotype-phenotype annotation, standard operating protocols, and the development of open source data analysis tools. Members of the IMPC may include research centers, funding organizations and corporations.

HIV & AIDS Costs & Use

HCSUS

Subject(s)
Content type(s)
Country
<<<!!!<<< This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information. Please go to www.ahrq.gov for current information. >>>!!!>>> HIV and AIDS Costs and Use is the first major research effort to collect information on a nationally representative sample of people in care for HIV infection. Also called the HIV Cost and Services Utilization Study (HCSUS), the core study is meant to help policymakers in the U.S. make informed decisions on the subject. The study describes the type of therapies available and costs of health care services for people with HIV/AIDS, as well as quality of care, social support, and non-medical services HIV/AIDS patients receive. Supplemental studies examine HIV care delivery in rural areas, prevalence of mental and substance abuse disorders, and other health issues of HIV/AIDS patients.